Bristol-Myers Squibb Co (BMY)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Giovanni Caforio
Employees:
32,200
345 PARK AVE, NEW YORK, NY 10154
2125464000

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma.

Data derived from most recent annual or quarterly report
Market Cap 158.53 Billion Shares Outstanding2.129 Billion Avg 30-day Volume 8.858 Million
P/E Ratio24.7753 Dividend Yield2.7403 EPS1.37
Price to Revenue3.4774 Debt to Equity1.2878 EBITDA18.127 Billion
Price to Book Value5.0288 Operating Margin18.1805 Enterprise Value192.831 Billion
Current Ratio1.443 EPS Growth2.338 Quick Ratio1.065
1 Yr BETA 0.2726 52-week High/Low 80.03 / 52.01 Profit Margin14.076
Operating Cash Flow Growth23.1089 Altman Z-Score2.6231 Free Cash Flow to Firm 14.851 Billion
Earnings Report2022-10-26
View SEC Filings from BMY instead.

View recent insider trading info

Bristol-Myers Squibb Co YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BMY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BMY

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-07-05 by YALE PHYLLIS R
  • 4: filed on 2022-07-05 by ARDUINI PETER J
  • 4: filed on 2022-07-05 by HIDALGO MEDINA MANUEL
  • 4: filed on 2022-07-05 by WEESE MICHELLE
  • 4: filed on 2022-07-05 by STORCH GERALD L
  • 4: filed on 2022-07-05 by RICE DERICA W
  • 4: filed on 2022-07-05 by BHATT DEEPAK
  • 4: filed on 2022-07-05 by HALLER JULIA A
  • 4: filed on 2022-07-05 by HIRAWAT SAMIT
  • 4: filed on 2022-07-05 by SAMUELS THEODORE R. II

    • Events (8k)

  • 8-K: filed on 2022-07-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-18:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-17:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-03-03:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-24:
    Item 8.01: Other Events
  • 8-K: filed on 2022-02-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-15:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    30 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    11.2 Thousand total shares from 2 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HIRAWAT SAMIT EVP,CHIEF MED.OFFR.,DRUG DEV.

    • Officer
    		 30,649 2022-07-01 2

    WEESE MICHELLE EVP, CORPORATE AFFAIRS

    • Officer
    		 6,858 2022-07-01 2

    STORCH GERALD L

    • Director
    		 71,991 2022-06-30 5

    YALE PHYLLIS R

    • Director
    		 15,400 2022-06-30 5

    ARDUINI PETER J

    • Director
    		 38,980 2022-06-30 5

    RICE DERICA W

    • Director
    		 11,408 2022-06-30 5

    HALLER JULIA A

    • Director
    		 15,655 2022-06-30 6

    SAMUELS THEODORE R. II

    • Director
    		 32,786 2022-06-30 5

    HIDALGO MEDINA MANUEL

    • Director
    		 5,589 2022-06-30 5

    BHATT DEEPAK

    • Director
    		 1,755 2022-06-30 3

    CAFORIO GIOVANNI BOARD CHAIR AND CEO

    • Officer
    • Director
    		 551,104 2022-06-13 6

    LEUNG SANDRA EVP, GENERAL COUNSEL

    • Officer
    		 399,083 2022-06-06 2

    GREENLEES SHARON SVP & CONTROLLER

    • Officer
    		 8,202 2022-05-02 2

    MILY ELIZABETH EVP, STRATEGY & BD

    • Officer
    		 24,036 2022-04-01 2

    SHANAHAN KARIN EVP, GLOB. PROD. DEV. & SUPPLY

    • Officer
    		 13,225 2022-04-01 3

    VESSEY RUPERT EVP, RESEARCH & EARLY DEV.

    • Officer
    		 59,508 2022-03-16 7

    BOERNER CHRISTOPHER S. EVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 41,966 2022-03-14 3

    SANTIAGO KAREN MURPHY SVP & CONTROLLER

    • Officer
    		 16,704 2022-03-14 2

    ELKINS DAVID V EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 247,368 2022-03-10 4

    POWELL ANN EVP, CHIEF HUMAN RESOURCES

    • Officer
    		 129,514 2022-03-10 1

    MEYERS GREGORY SCOTT EVP, CHIEF DIGITAL & TECH OFF.

    • Officer
    		 28,368 2022-03-10 3

    PRICE PAULA A

    • Director
    		 8,255 2022-02-01 3

    VOUSDEN KAREN H

    • Director
    		 21,415 2022-02-01 1

    VON AUTENRIED PAUL EVP, CHIEF INFORMATION OFFICER

    • Officer
    		 63,536 2021-11-22 1

    DUBOW ADAM SVP,CHIEFCOMPLIANCE&ETHICSOFF.

    • Officer
    		 14,749 2021-07-30 0

    BONNEY MICHAEL W

    • Director
    		 9,342 2021-06-30 0

    EID JOSEPH SVP,HEAD GLOB. MEDICAL AFFAIRS

    • Officer
    		 13,794 2021-06-03 0

    SCHMUKLER LOUIS S EVP,PRES.,GLOB.PROD. & SUPPLY

    • Officer
    		 31,956 2021-05-10 0

    BERTOLINI ROBERT J

    • Director
    		 26,648 2021-03-31 0

    EMMENS MATTHEW

    • Director
    		 26,999 2021-03-31 0

    PALIWAL DINESH C

    • Director
    		 40,501 2021-03-31 0

    SATO VICKI L

    • Director
    		 0 2021-02-01 0

    AHMED NADIM EVP AND PRESIDENT, HEMATOLOGY

    • Officer
    		 40,855 2020-12-31 0

    LACY ALAN J

    • Director
    		 0 2020-06-30 0

    GROBSTEIN MICHAEL

    • Director
    		 0 2020-06-30 0

    BANCROFT CHARLES A EVP, HEAD OF INTEGRATION

    • Officer
    		 437,534 2020-03-10 0

    ELICKER JOHN E EVP, INVESTOR RELATIONS

    • Officer
    		 70,946 2020-03-10 0

    METCALFE KATHRYN EVP, CORPORATE AFFAIRS

    • Officer
    		 0 2020-03-10 0

    BIONDI PAUL SVP, HEAD OF STRATEGY & BD

    • Officer
    		 6,214 2019-10-02 0

    LYNCH THOMAS J. JR. EVP & CHIEF SCIENTIFIC OFFICER

    • Officer
    		 22,223 2019-04-03 0

    STORCH GERALD L

    STORCH GERALD L

    • Director
    		 0 2018-09-30 5

    BASELGA JOSE

    • Director
    		 No longer subject to file 2018-09-30 0

    GORDON MURDO EVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 No longer subject to file 2018-08-01 0

    CALDARELLA JOSEPH C SVP & CONTROLLER

    • Officer
    		 48,076 2017-09-06 0

    NIELSEN ANNE CHIEF COMPLIANCE & ETHICS OFF

    • Officer
    		 37,974 2017-09-03 0

    ANDREOTTI LAMBERTO

    • Director
    		 1,176,844 2017-04-06 0

    CUSS FRANCIS M EVP & CSO

    • Officer
    		 321,906 2017-03-10 0

    BLIN EMMANUEL SVP, CHIEF STRATEGY OFFICER

    • Officer
    		 20,138 2017-03-10 0

    WEST TOGO D JR

    • Director
    		 0 2017-02-01 0

    GLIMCHER LAURIE H M.D.

    • Director
    		 0 2017-02-01 0

    CAMPBELL LEWIS B

    • Director
    		 2,110 2016-03-08 0

    CORNELIUS JAMES M

    • Director
    		 79,851 2015-03-31 0

    MOED SAMUEL J SVP, STRAT PLAN & ANALYSIS

    • Officer
    		 31,615 2015-03-13 0

    DANIELS BRIAN SVP GLOBAL DEV & MED AFFAIRS

    • Officer
    		 No longer subject to file 2014-07-01 0

    HELLER FRANCES K SVP, BUSINESS DEVELOPMENT

    • Officer
    		 4,218 2014-03-10 0

    SIGAL ELLIOT EVP, CSO & PRESIDENT R&D

    • Officer
    • Director
    		 195,300 2013-06-03 0

    CAZALA BEATRICE J EVP COMMERCIAL OPERATIONS

    • Officer
    		 177,118 2013-05-31 0

    FREEH LOUIS J

    • Director
    		 0 2013-02-01 0

    WILLIAMS R SANDERS

    • Director
    		 0 2013-02-01 0

    CELENTANO JOHN E SVP HR PUBLIC AFFAIRS & PHILAN

    • Officer
    		 142,142 2012-03-06 0

    LEVIN JEREMY M SVP STRAT TRANSACTIONS

    • Officer
    		 43,689 2011-10-01 0

    CARLO DE NOTARISTEFANI PRES TECH OPS & SUPP FNCTNS

    • Officer
    		 8,432 2011-06-14 0

    HOOPER ANTHONY C SVP COMOPS PRES USJAP INT

    • Officer
    		 208,419 2011-05-13 0

    JOHANSSON LEIF

    • Director
    		 0 2011-02-01 0

    ZITO ROBERT T SVP & CHIEF COMM OFFICER

    • Officer
    		 35,469 2010-03-06 0

    MCBRIDE ANTHONY A SVP HUMAN RESOURCES

    • Officer
    		 34,292 2010-03-06 0

    HUET JEAN-MARC EVP & CFO

    • Officer
    		 25,000 2009-04-30 0

    ROBINSON JAMES D III

    • Director
    		 0 2007-12-31 0

    BONFIELD ANDREW R J EVP & CFO

    • Officer
    		 150,206 2007-10-01 0

    BEAR STEPHEN E SVP, HUMAN RESOURCES

    • Officer
    		 76,257 2007-09-10 0

    COFFMAN VANCE D

    • Director
    		 44,870 2006-09-29 0

    DOLAN PETER R FORMER CEO

    • Officer
    • Director
    		 606,946 2006-09-08 0

    BODNAR ANDREW G SVP, STRAT & MED & EXT AFFAIRS

    • Officer
    		 323,464 2006-09-08 0

    ALLEN ROBERT E

    • Director
    		 2,500 2006-05-02 0

    GLIMCHER LAURIE H MD

    • Director
    		 2,500 2006-05-02 0

    SULLIVAN LOUIS W

    • Director
    		 22,932 2006-03-31 0

    GERSTNER LOUIS V JR

    • Director
    		 42,402 2006-03-09 0

    MCGOLDRICK JOHN L EXECUTIVE VP

    • Officer
    		 223,999 2006-03-07 0

    DIXON WENDY L CMO & PRES, GLOBAL MARKETING

    • Officer
    		 128,868 2006-03-07 0

    HOWSON TAMAR D SVP, CORP & BUS DEVELOPMENT

    • Officer
    		 112,671 2006-03-07 0

    WILLARD RICHARD K SVP & GENERAL COUNSEL

    • Officer
    		 203,300 2006-03-07 0

    ZABOR DAVID L VP STRAT BUS INITIATIVES

    • Officer
    		 104,665 2006-03-07 0

    DWYER EDWARD M VICE PRESIDENT & TREASURER

    • Officer
    		 41,257 2006-03-07 0

    WOLGEMUTH RICHARD L SVP, GLOBAL REG SCIENCES

    • Officer
    		 68,936 2006-03-07 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HIRAWAT SAMIT - Officer EVP,CHIEF MED.OFFR.,DRUG DEV.

    		2022-07-05 12:28:08 -0400 2022-07-01 M 9,356 a 26,078 direct 0.3423 -1.2507 0.3423 2 -1.2507 6

    HIRAWAT SAMIT - Officer EVP,CHIEF MED.OFFR.,DRUG DEV.

    		2022-07-05 12:28:08 -0400 2022-07-01 F 4,786 $76.84 d 21,292 direct 0.3423 -1.2507 0.3423 2 -1.2507 6

    HIRAWAT SAMIT - Officer EVP,CHIEF MED.OFFR.,DRUG DEV.

    		2022-07-05 12:28:08 -0400 2022-07-01 M 9,356 d 9,357 direct

    WEESE MICHELLE - Officer EVP, CORPORATE AFFAIRS

    		2022-07-05 12:29:58 -0400 2022-07-01 M 1,885 a 1,885 direct 0.3423 -1.2507 0.3423 2 -1.2507 6

    WEESE MICHELLE - Officer EVP, CORPORATE AFFAIRS

    		2022-07-05 12:29:58 -0400 2022-07-01 F 682 $76.84 d 1,203 direct 0.3423 -1.2507 0.3423 2 -1.2507 6

    WEESE MICHELLE - Officer EVP, CORPORATE AFFAIRS

    		2022-07-05 12:29:58 -0400 2022-07-01 M 1,885 d 5,655 direct

    HALLER JULIA A - Director

    		2022-07-05 12:28:27 -0400 2022-06-30 A 438 $77.00 a 15,655 direct

    SAMUELS THEODORE R. II - Director

    		2022-07-05 12:27:30 -0400 2022-06-30 A 633 $77.00 a 32,786 direct

    ARDUINI PETER J - Director

    		2022-07-05 12:31:06 -0400 2022-06-30 A 438 $77.00 a 38,980 direct

    HIDALGO MEDINA MANUEL - Director

    		2022-07-05 12:30:40 -0400 2022-06-30 A 97 $77.00 a 5,589 direct

    BHATT DEEPAK - Director

    		2022-07-05 12:28:47 -0400 2022-06-30 A 18 $77.00 a 1,755 direct

    STORCH GERALD L - Director

    		2022-07-05 12:29:40 -0400 2022-06-30 A 471 $77.00 a 71,991 direct

    YALE PHYLLIS R - Director

    		2022-07-05 12:31:30 -0400 2022-06-30 A 438 $77.00 a 15,400 direct

    RICE DERICA W - Director

    		2022-07-05 12:29:18 -0400 2022-06-30 A 471 $77.00 a 11,408 direct

    BHATT DEEPAK - Director

    		2022-06-16 18:09:00 -0400 2022-06-14 A 1,737 $72.87 a 1,737 direct

    CAFORIO GIOVANNI - Director - Officer BOARD CHAIR AND CEO

    		2022-06-14 17:58:25 -0400 2022-06-13 S 30,000 $74.04 d 551,104 direct -0.5478 6.3955 1.7431 9.5317 8 -0.5478 2

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 18:45:03 UTC 1.9924 0.3276 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 18:15:04 UTC 1.9924 0.3276 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 17:45:04 UTC 1.9924 0.3276 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 17:15:05 UTC 1.9924 0.3276 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 16:45:04 UTC 1.9786 0.3414 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 16:15:04 UTC 1.9786 0.3414 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 15:45:04 UTC 1.9786 0.3414 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 15:15:05 UTC 1.9786 0.3414 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 14:45:04 UTC 1.9786 0.3414 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 14:15:05 UTC 1.9786 0.3414 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 13:45:04 UTC 2.0676 0.2524 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 13:15:04 UTC 2.0676 0.2524 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-12 12:45:04 UTC 2.0676 0.2524 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-11 22:15:03 UTC 2.0676 0.2524 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-11 21:45:04 UTC 2.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-11 21:15:03 UTC 2.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-11 20:45:04 UTC 2.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-11 20:15:03 UTC 2.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-11 19:45:04 UTC 2.07 0.25 0
    BRISTOL-MYERS SQUIBB CO BMY 2022-08-11 19:15:05 UTC 2.07 0.25 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Master Neutral Fund BMY -13.0 shares, $-783.77 2020-09-30 N-PORT
    FundVantage Trust- Gotham Neutral 500 Fund BMY -42.0 shares, $-2651.46 2021-03-31 N-PORT
    American Century Capital Portfolios, Inc.- AC Alternatives Market Neutral Value Fund BMY -5384.0 shares, $-318571.28 2021-09-30 N-PORT
    PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments BMY -2741.0 shares, $-206315.07 2022-04-30 N-PORT

    Elevate your investments